SLC43A3
Equilibrative nucleobase transporter 1
Also known as: DKFZp762A227, Eeg1, FOAP-13, PRO1659, S43A3_HUMAN, SEEEG-1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NBI5
- Gene
- SLC43A3
- Ensembl
- ENSG00000134802
- Chromosome
- 11
- Canonical length
- 491 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Nucleoplasm,Vesicles,Plasma membrane
OverviewNCBI Gene
Enables adenine transmembrane transporter activity; guanine transmembrane transporter activity; and xenobiotic transmembrane transporter activity. Involved in hypoxanthine transport. Located in basolateral plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
491 residues, UniProt reviewed canonical sequence.
>Q8NBI5|SLC43A3
1 MAGQGLPLHV ATLLTGLLEC LGFAGVLFGW PSLVFVFKNE DYFKDLCGPD AGPIGNATGQ
61 ADCKAQDERF SLIFTLGSFM NNFMTFPTGY IFDRFKTTVA RLIAIFFYTT ATLIIAFTSA
121 GSAVLLFLAM PMLTIGGILF LITNLQIGNL FGQHRSTIIT LYNGAFDSSS AVFLIIKLLY
181 EKGISLRASF IFISVCSTWH VARTFLLMPR GHIPYPLPPN YSYGLCPGNG TTKEEKETAE
241 HENRELQSKE FLSAKEETPG AGQKQELRSF WSYAFSRRFA WHLVWLSVIQ LWHYLFIGTL
301 NSLLTNMAGG DMARVSTYTN AFAFTQFGVL CAPWNGLLMD RLKQKYQKEA RKTGSSTLAV
361 ALCSTVPSLA LTSLLCLGFA LCASVPILPL QYLTFILQVI SRSFLYGSNA AFLTLAFPSE
421 HFGKLFGLVM ALSAVVSLLQ FPIFTLIKGS LQNDPFYVNV MFMLAILLTF FHPFLVYREC
481 RTWKESPSAI ALocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC43A3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 11
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 135 nTPM
Expression across tissuesHPA
Tissue
- liver: 135 nTPM
- thyroid gland: 72 nTPM
- adipose tissue: 59 nTPM
- bone marrow: 55 nTPM
- breast: 47 nTPM
- lung: 45 nTPM
Single-cell type
- erythrocyte progenitors: 11 nCPM
- epicardial cells: 6.8 nCPM
- mast cells: 6.8 nCPM
- pdcs: 6.4 nCPM
- myosatellite cells: 6.3 nCPM
- monocytes: 5.8 nCPM
Immune cell
- non-classical monocyte: 147 nTPM
- intermediate monocyte: 127 nTPM
- classical monocyte: 106 nTPM
- plasmacytoid DC: 86 nTPM
- myeloid DC: 86 nTPM
- total PBMC: 61 nTPM
Brain region
- thalamus: 20 nTPM
- white matter: 14 nTPM
- cerebral cortex: 12 nTPM
- pons: 12 nTPM
- hypothalamus: 11 nTPM
- medulla oblongata: 11 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.86
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.47
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- adenine transmembrane transporter activity
- fatty acid transmembrane transporter activity
- guanine transmembrane transporter activity
- xenobiotic transmembrane transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- MFS transporter superfamily
- Equilibrative nucleobase transporter 1
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SLC43A3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC43A3 as an antibody target. Whether an autoantibody or antibody against SLC43A3 could matter depends on whether native SLC43A3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC43A3 is annotated at the cell surface, where native SLC43A3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC43A3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...